Author:
Porcari Aldostefano,Maurer Mathew S.,Gillmore Julian D.
Publisher
Springer Nature Switzerland
Reference51 articles.
1. Kelly J, Colon W, Lai Z, Lashuel H, McCulloch J, McCutchen S, et al. Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid. In: Advances in protein chemistry. Elsevier; 1997. p. 161–81. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0065323308603216.
2. Porcari A, Fontana M, Gillmore JD. Transthyretin cardiac amyloidosis. Cardiovasc Res. 2023;118(18):3517–35. https://doi.org/10.1093/cvr/cvac119.
3. Zhao L, Buxbaum JN, Reixach N. Age-related oxidative modifications of transthyretin modulate its amyloidogenicity. Biochemistry. 2013;52(11):1913–26.
4. Mangione PP, Porcari R, Gillmore JD, Pucci P, Monti M, Porcari M, et al. Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis. Proc Natl Acad Sci U S A. 2014;111(4):1539–44.
5. Emdin M, Aimo A, Rapezzi C, Fontana M, Perfetto F, Seferović PM, et al. Treatment of cardiac transthyretin amyloidosis: an update. Eur Heart J. 2019;40(45):3699–706.